MedPath

Hypermetabolism, cachexia and survival in cancer

Not Applicable
Completed
Conditions
Hypermetabolism, malnutrition and survival in cancer patients.
Cancer
Registration Number
ISRCTN46152275
Lead Sponsor
Medical Oncology, Cochin Teaching Hospital, AP-HP, Paris Descartes University
Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/28356274/ (added 27/11/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
390
Inclusion Criteria

Cancer outpatients and inpatients over 18 years. Patients were recruited as they benefit from a routinely evaluation before systemic treatment initiation. We included all cancer patients, any stage, evaluated before systemic treatment initiation including adjuvant chemotherapy.

Exclusion Criteria

1. Patients who were not able to undergo indirect calorimetry (claustrophobia, oxygen therapy, flat nose bridge)
2. Patients who underwent anti-cancer therapy within the previous 30 days.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath